UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The UK EndoVascular Aneurysm Repair (EVAR) trials: randomised trials of EVAR versus standard therapy

Health technology assessment (Winchester, England), 2012-02, Vol.16 (9), p.1-218

2012

Volltextzugriff (PDF)

Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies

Health technology assessment (Winchester, England), 2005-03, Vol.9 (9), p.1-156

2005

Volltextzugriff (PDF)

Does therapeutic writing help people with long-term conditions? Systematic review, realist synthesis and economic considerations

Health technology assessment (Winchester, England), 2016-04, Vol.20 (27), p.vii-368

2016

Volltextzugriff (PDF)

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis

Health technology assessment (Winchester, England), 2011-09, Vol.15 (31), p.1-178

2011

Volltextzugriff (PDF)

The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation

Health technology assessment (Winchester, England), 2012, Vol.16 (43), p.1-129

2012

Volltextzugriff (PDF)

Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation

Health technology assessment (Winchester, England), 2009-01, Vol.13 (1), p.iii

2009

Volltextzugriff (PDF)

Clinical and economic evaluation of laparoscopic surgery compared with medical management for gastro-oesophageal reflux disease: 5-year follow-up of multicentre randomised trial (the REFLUX trial)

Health technology assessment (Winchester, England), 2013-06, Vol.17 (22), p.1-167

2013

Volltextzugriff (PDF)

Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer

Health technology assessment (Winchester, England), 2010-10, Vol.14 (Suppl. 2), p.33-39

2010

Volltextzugriff (PDF)

Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer

Health technology assessment (Winchester, England), 2010-05, Vol.14 Suppl 1 (Suppl 1), p.47-53

2010

Volltextzugriff (PDF)

Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck

Health technology assessment (Winchester, England), 2009-10, Vol.13 Suppl 3 (Suppl 3), p.49-54

2009

Volltextzugriff (PDF)

Rituximab for the treatment of rheumatoid arthritis

Health technology assessment (Winchester, England), 2009-09, Vol.13 Suppl 2 (Suppl 2), p.23-29

2009

Volltextzugriff (PDF)

Corrigendum: Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation

Health technology assessment (Winchester, England), 2015-05, Vol.17 (31), p.281-282

2015

Volltextzugriff (PDF)

Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention

Health technology assessment (Winchester, England), 2010-05, Vol.14 Suppl 1 (Suppl 1), p.31-38

2010

Volltextzugriff (PDF)

Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation

Health technology assessment (Winchester, England), 2013-07, Vol.17 (31), p.1-278

2013

Volltextzugriff (PDF)

Corrigendum: Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation

Health technology assessment (Winchester, England), 2014-11, Vol.17 (31)

2014

Volltextzugriff (PDF)

The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial

Health technology assessment (Winchester, England), 2008-09, Vol.12 (31), p.1-181

2008

Volltextzugriff (PDF)

Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck

Health technology assessment (Winchester, England), 2009-10, Vol.13 (Suppl 3), p.49-54

2009

Volltextzugriff (PDF)

Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention

Health technology assessment (Winchester, England), 2010-05, Vol.14 (Suppl 1), p.31-38

2010

Volltextzugriff (PDF)

Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer

Health technology assessment (Winchester, England), 2010-05, Vol.14 (Suppl 1)

2010

Volltextzugriff (PDF)

Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer

Health technology assessment (Winchester, England), 2010-05, Vol.14 (Suppl 1), p.47-53

2010

Volltextzugriff (PDF)

Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer

Health technology assessment (Winchester, England), 2010-10, Vol.14 (Suppl 2), p.33-39

2010

Volltextzugriff (PDF)

Rituximab for the treatment of rheumatoid arthritis

Health technology assessment (Winchester, England), 2009-09, Vol.13 (Suppl 2), p.23-29

2009

Volltextzugriff (PDF)

Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention

Health technology assessment (Winchester, England), 2010-05, Vol.14 Suppl 1

2010

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieHealth Technology Assessment

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Kollektion

Free E-Journal (出版社公開部分のみ）
(23)
MEDLINE
(14)

Zeitschrift / Serie

Hta On Dvd/health Technology Assessment
(11)

Menü

Weitere Dienste

Einstellungen

The UK EndoVascular Aneurysm Repair (EVAR) trials: randomised trials of EVAR versus standard therapy

Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies

Does therapeutic writing help people with long-term conditions? Systematic review, realist synthesis and economic considerations

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis

The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation

Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation

Clinical and economic evaluation of laparoscopic surgery compared with medical management for gastro-oesophageal reflux disease: 5-year follow-up of multicentre randomised trial (the REFLUX trial)

Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer

Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer

Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck

Rituximab for the treatment of rheumatoid arthritis

Corrigendum: Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation

Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention

Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation

Corrigendum: Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation

The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial

Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck

Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention

Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer

Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer

Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer

Rituximab for the treatment of rheumatoid arthritis

Prasugrel for the treatment of acute coronary artery syndromes with percutaneous coronary intervention

Aktive Filter

Suchergebnisse filtern